Monday, January 9, 2012

Bristol agrees to pay $2.5B for antiviral maker Inhibitex

Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/drjyCduTtWCcbOwUCidawyCicNcuMc

January 9, 2012
More than 2,700 companies nationwide are saving on lab supplies, shipping, news distribution, office products and more through the BIO Business Solutions cost-savings program. Find out how.

The news summaries appearing in BIO SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The information is not compiled or summarized by BIO. Questions and comments should be directed to SmartBrief at bio@smartbrief.com.

  Today's Top Story 
 
Developing Improved, Safer Processes
This webinar describes how reaction calorimetry is used to develop improved scalable processes. Process development methods to manage delayed initiation or uncontrolled exotherm are explained using real case studies at Johnson and Johnson. Register for the webinar here.
  Health Care & Policy 
 
  • FDA approved more drugs in 2011 than in 2010
    Better communication between drugmakers and the FDA led to more drug approvals last year. The FDA approved 30 new drugs in 2011, compared with 21 the year before. Advance consultations on the FDA's data requirements are bearing fruit, according to pharmaceutical analysts and executives. Bloomberg (1/5) LinkedInFacebookTwitterEmail this Story
  • Researchers prime white blood cells to protect against HIV
    Australian researchers are exploring a method to increase the ability of T cells to fight HIV using HLA molecules. "We'll start by using blood samples from HIV patients, as we know that they have HIV-specific T cells, infusing the blood with HLA molecules to try to stimulate these T cells," said researcher Dr. Lloyd D'Orsogna from Murdoch University's Institute for Immunology and Infectious Disease. Results of successful trials of the method could lead to a vaccine-like treatment to prevent HIV infection. ScienceNetwork WA (Australia) (1/6) LinkedInFacebookTwitterEmail this Story
  • Transgenic worms produce silk as strong as a spider's
    Bioengineered silkworms produced fibers as strong as spider silk that could be used in biomedical and surgical applications, according to scientists from the University of Wyoming, Laramie; Zhejiang University in China; and the University of Notre Dame in Illinois' Eck Institute for Global Health. The material can be used for sutures and has potential for wound dressings, microcapsules and artificial ligaments, tendons and tissue scaffolds. Spider silk is stronger than silk from silkworms, but it can't be farmed because spiders are territorial and cannibalistic. Genetic Engineering & Biotechnology News (1/3) LinkedInFacebookTwitterEmail this Story
Your job as an Exchange administrator isn't easy. You have to respond to lost messages, handle email discovery requirements, and keep everything up and running. Is there an easy way to manage your Exchange environment — and do it under budget? Learn about the challenges faced by three real organizations, and how using the right solution brought them peace of mind.
  Company & Financial News 
  • Syndax, Ventana to devise companion diagnostic test for cancer drug
    Syndax Pharmaceuticals partnered with Ventana Medical Systems in the development of a companion diagnostic test to identify nonsmall-cell lung cancer patients suited for treatment with a combination of erlotinib and Syndax's entinostat. A Phase II study showed that patients with high levels of e-cadherin in their tumors survived four months longer with erlotinib and entinostat compared with an erlotinib and placebo combo. Pharmaceutical Business Review Online (1/6) LinkedInFacebookTwitterEmail this Story
  • XOMA restructures to develop anti-inflammatory agent
    XOMA plans to focus on the development of anti-inflammatory agent XOMA 052. The biotech firm expects to save about $14 million this year, partly through the use of a contract manufacturer. Meanwhile, interim CEO John Varian is taking over permanently. Reuters (1/5) LinkedInFacebookTwitterEmail this Story
  Featured Content 
 
Most Popular Headlines from Last Week
Results based on number of times each story was clicked by readers.

  Food & Agriculture 
  • Biotech bill won't weaken state rights, says Indian adviser
    India's Department of Biotechnology adviser S.R. Rao clarified that the new Biotechnology Regulatory Authority of India bill doesn't have any provisions taking away state rights over agriculture and health, in response to apprehensions of several states and farmer groups. The commercialization of health care and farming-related biotechnology products would still be subject to central or state laws, Rao explained. The Times of India/Times News Network (1/7) LinkedInFacebookTwitterEmail this Story
  Hot Topics 

Top five news stories selected by BIO SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Industrial & Environmental 
  • EIA: Ethanol production pushed to new high last week
    Daily ethanol production in the U.S. for the week ending Dec. 30, 2011, amounted to a record high of 963,000 barrels on average, an increase of 1,000 barrels from the previous week, according to the Energy Information Administration. While official data on the country's total ethanol production in 2011 are yet to be released, last year's overall ethanol output could hit about 13.78 billion gallons based on weekly reports. DomesticFuel.com (1/6) LinkedInFacebookTwitterEmail this Story
  News from BIO 
  • Ship with FedEx
    BIO has teamed up with FedEx to offer member companies discounts of up to 35% off select FedEx Express, FedEx Ground and FedEx Home Delivery services through the BIO Business Solutions cost-savings program. Learn more. LinkedInFacebookTwitterEmail this Story
Learn more about BIO ->Conferences  |  Join BIO  |  Media  |  Issues  |  Industry

The Buzz(CORPORATE ANNOUNCEMENTS)

Let’s Go Design: Episode #7
Before moving into the last stage of production, the team calls a last minute “sanity check” on the final design of the hot rod baby buggy. They look at each of the main components to make sure it rides smoothly. Watch them at work at LetsGoDesign.tv

Interested in learning more about advertising in BIO SmartBrief? Contact Meryl Harold at (202) 407-7828 or mharold@smartbrief.com.  

  SmartQuote 
Knowledge can be communicated, but wisdom cannot. A man can find it, he can live it, he can be filled and sustained by it, but he cannot utter or teach it."
--Hermann Hesse,
German-Swiss writer and poet


LinkedInFacebookTwitterEmail this Story

 
 
This SmartBrief was created for jmabs1@gmail.com
 
Subscriber Tools
     
Update account information | Change e-mail address | Unsubscribe | Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent BIO SmartBrief Issues:   Lead Editor:  Tom Parks
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information

No comments: